Demineralized Bone Matrix (DBM) Market to Reach USD 2.04 Billion by 2031, Growing at a CAGR of 5.9%

The Demineralized Bone Matrix (DBM) Market was valued at USD 1.29 billion in 2023 and is projected to reach USD 2.04 billion by 2031, growing at a compound annual growth rate (CAGR) of 5.9% during the forecast period from 2024 to 2031.

Download free sample Report: https://www.snsinsider.com/sample-request/3449 

Market Dynamics

• Increasing Orthopedic Surgeries: Growing number of orthopedic procedures and surgeries drive demand for DBM as a bone graft substitute.
• Advancements in Medical Technology: Technological innovations in bone grafting materials and surgical techniques enhance market growth.
• Rising Geriatric Population: Higher incidence of bone-related disorders among elderly population supports market expansion.
• Regulatory Support: Favorable regulatory frameworks promoting safe and effective use of DBM in medical applications boost market adoption.

Key Players

• Medtronic plc
• Johnson & Johnson Services, Inc. (DePuy Synthes)
• Zimmer Biomet Holdings, Inc.
• Stryker Corporation
• SeaSpine Holdings Corporation
• RTI Surgical Holdings, Inc.
• NuVasive, Inc.
• Kuros Biosciences AG
• Orthofix Medical Inc.
• MTF Biologics

Key Segments Covered in DBM Market:

• By Form:
  • Gel
  • Putty
  • Paste
  • Others
• By Application:
  • Spinal Fusion
  • Trauma
  • Orthopedic Surgery
  • Others
• By End User:
  • Hospitals
  • Ambulatory Surgical Centers
  • Orthopedic Clinics
  • Others

Segment Analysis

• Spinal Fusion application segment dominates the market due to increasing prevalence of spinal disorders and surgeries.
• Hospitals hold the largest share among end users, attributed to high patient inflow and advanced surgical facilities.

Recent Developments

• In January 2023, Medtronic launched a new DBM gel formulation designed for improved handling and surgical outcomes in orthopedic procedures.
• In August 2022, Zimmer Biomet introduced a next-generation DBM putty with enhanced biocompatibility and osteoinductive properties.

Regional Analysis

• North America led the market in 2023, driven by robust healthcare infrastructure, high incidence of orthopedic disorders, and extensive R&D activities.
• Europe follows closely, supported by increasing geriatric population and rising investments in healthcare.

Key Takeaways

• The DBM Market growth is driven by rising demand for bone graft substitutes in orthopedic surgeries and spinal fusion procedures.
• Technological advancements and product innovations enhance efficacy and safety of DBM, fostering market expansion.
• North America and Europe are key markets, while Asia-Pacific presents lucrative opportunities due to improving healthcare infrastructure and rising adoption of advanced medical treatments.

Enquiry About DBM Market Report: https://www.snsinsider.com/enquiry/3449 

Table of Content

1. Introduction
2. Research Methodology
3. DBM Market Dynamics
4. Impact Analysis (COVID-19, etc.)
5. Value Chain Analysis
6. Porter’s 5 Forces Model
7. PEST Analysis
8. Market Segmentation (Form, Application, End User)
9. Regional Analysis
10. Company Profiles
11. Competitive Landscape
12. Use Cases and Best Practices
13. Conclusion

Access Full Report: https://www.snsinsider.com/reports/demineralized-bone-matrix-market-3449 

Other Related Report

Medical Mask Market Opportunity

Medical Nonwoven Disposable Market Opportunity

Medical Swabs Market Opportunity

Medical Tape and Bandage Market Opportunity

Medical Waste Containers Market Opportunity